Sterne Agee Maintains a 'Buy' on Ingram Micro (IM); Brightpoint (CELL) Acquisition Greatly Strengthens Presence

July 2, 2012 2:23 PM EDT Send to a Friend
Get Alerts IM Hot Sheet
Price: $18.01 -0.66%

Rating Summary:
    2 Buy, 6 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 18 | New: 13
Trade IM Now!
Sterne Agee maintains a 'Buy' on Ingram Micro (NYSE: IM) price target of $24.00.

Analyst, Shaw Wu, said, "We view this acquisition positively as it makes a lot of strategic sense. Brightpoint (Nasdaq: CELL) beefs up IM's presence in the fast-growing mobile devices space and will be margin accretive. We find IM shares attractive trading at a 20% discount to its tangible book value of $22."

The acquisition deal is expected to be accretive to IM's FY13 (by $0.18) and FY14 (by $0.35), however Wu is maintaining his estimates on IM.

For an analyst ratings summary and ratings history on Ingram Micro click here. For more ratings news on Ingram Micro click here.

Shares of Ingram Micro closed at $17.47 yesterday, with a 52 week range of $15.45-$19.80.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Mergers and Acquisitions

Related Entities

Sterne Agee

Add Your Comment